| Schedule of Notes Payable Related Party |
Notes
payable, related parties, consists of the following at March 31, 2024 and December 31, 2023, respectively:
Schedule
of Notes Payable Related Party
| |
|
March 31, |
|
|
December 31, |
|
| |
|
2024 |
|
|
2023 |
|
| |
|
|
|
|
|
|
| On March 19, 2024, the Company,
through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $50,000 from Joerg Sommer, our President, pursuant
to an unsecured promissory note, maturing on March 1, 2027, that carries a 10% interest rate. |
|
$ |
50,000 |
|
|
$ |
- |
|
| |
|
|
|
|
|
|
|
|
| On March 15, 2024, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $26,116 to Joerg Sommer, our
President, maturing on March 1, 2027, that carries a 10% interest rate. The note was issued in exchange for the cancellation of another
promissory note, consisting of $25,000 of principal and $1,116 of accrued interest. |
|
|
26,116 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| On March 15, 2024, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $1,803,398 to Dr. John McCabe,
an affiliate investor, maturing on March 1, 2027, that carries a 7% interest rate. The note was issued in exchange for the cancellation
of a $840,740 convertible note, consisting of $750,000 of principal and $90,740 of accrued interest., and other promissory notes
in the aggregate amount of $962,658, consisting of a total of $850,000 of principal and $112,658 of accrued interest. |
|
|
1,803,398 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| On March 15, 2024, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $337,000 to Dr. Kenneth Perego,
II, M.D., our Vice Chairman of the Board, maturing on March 1, 2027, that carries a 10% interest rate. The note was issued in exchange
for the cancellation of promissory notes in the aggregate amount of $337,000, consisting entirely of principal. |
|
|
337,000 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| On March 15, 2024, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., issued an unsecured promissory note in the amount of $27,467 to Isiah L. Thomas,
III, our Chairman of the Board and CEO, maturing on March 1, 2027, that carries a 10% interest rate. The note was issued in exchange
for the cancellation of another promissory note, consisting of $24,500 of principal and $2,967 of accrued interest. |
|
|
27,467 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| On March 12, 2024, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $100,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman
of the Board, pursuant to an unsecured promissory note due on demand that carries a 10% interest rate. |
|
|
100,000 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| On March 1, 2024, the Company, through its
wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $100,000 from Dr. John McCabe, an affiliate investor, pursuant
to an unsecured promissory note, maturing on March 1, 2025, that carried an 8% interest rate. The note was cancelled on March 15,
2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| On February 26, 2024, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $27,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman
of the Board, pursuant to an unsecured promissory note due on demand that carries a 10% interest rate. |
|
|
27,000 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| On January 29, 2024, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $50,000 from Dr. John McCabe, an affiliate investor, pursuant
to an unsecured promissory note, maturing on January 29, 2025, that carried an 8% interest rate. The note was cancelled on March
15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| On January 11, 2024, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $10,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman
of the Board, pursuant to an unsecured promissory note due on demand that carries a 10% interest rate. |
|
|
10,000 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| On January 8, 2024, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $10,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman
of the Board, pursuant to an unsecured promissory note due on demand that carries a 10% interest rate. |
|
|
10,000 |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| On November 28, 2023, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $60,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman
of the Board, pursuant to an unsecured promissory note due on demand that carries a 10% interest rate. |
|
|
60,000 |
|
|
|
60,000 |
|
| |
|
|
|
|
|
|
|
|
| On October 11, 2023, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $25,000 from the Company’s President, Joerg Sommer,
pursuant to an unsecured promissory note due on demand that carries a 10% interest rate. The note was cancelled on March 15, 2024,
in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
25,000 |
|
| |
|
|
|
|
|
|
|
|
| On September 11, 2023, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $52,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman
of the Board, pursuant to an unsecured promissory note due on demand that carries a 10% interest rate. The note was cancelled on
March 15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
52,000 |
|
| |
|
|
|
|
|
|
|
|
| On August 31, 2023, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $4,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman
of the Board, pursuant to an unsecured promissory note due on demand that carries a 6% interest rate. The note was cancelled on March
15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
4,000 |
|
| |
|
|
|
|
|
|
|
|
| On August 14, 2023, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $6,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman
of the Board, pursuant to an unsecured promissory note due on demand that carries a 6% interest rate. The note was cancelled on March
15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
6,000 |
|
| |
|
|
|
|
|
|
|
|
| On August 5, 2022, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $50,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman
of the Board, pursuant to an unsecured promissory note due on demand that carries a 6% interest rate. The note was cancelled on March
15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
50,000 |
|
| |
|
|
|
|
|
|
|
|
| On August 2, 2022, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $4,500 from Isiah L. Thomas, III, our Chairman of the Board
and CEO, pursuant to an unsecured promissory note due on demand that carries a 6% interest rate. The note was cancelled on March
15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
4,500 |
|
| |
|
|
|
|
|
|
|
|
| On June 13, 2022, the Company, through its
wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $100,000 from Dr. John McCabe, an affiliate investor, pursuant
to an unsecured promissory note, maturing on January 1, 2024, that carries an 8% interest rate. The note was cancelled on March 15,
2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
100,000 |
|
| |
|
|
|
|
|
|
|
|
| On July 7, 2022, the Company, through its
wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $5,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman of
the Board pursuant to an unsecured promissory note due on demand that carries a 6% interest rate. The note was cancelled on March
15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
5,000 |
|
| |
|
|
|
|
|
|
|
|
| On June 3, 2022, the Company, through its
wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $10,000 from Isiah L. Thomas, III, our Chairman of the Board
and CEO, pursuant to an unsecured promissory note due on demand that carries a 6% interest rate. The note was cancelled on March
15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
10,000 |
|
| |
|
|
|
|
|
|
|
|
| On May 5, 2022, the Company, through its
wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $10,000 from Isiah L. Thomas, III, our Chairman of the Board
and CEO, pursuant to an unsecured promissory note due on demand that carries a 6% interest rate. The note was cancelled on March
15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
10,000 |
|
| |
|
|
|
|
|
|
|
|
| On May 5, 2022, the Company, through its
wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $20,000 from Dr. Kenneth Perego, II, M.D., our Vice Chairman
of the Board, pursuant to an unsecured promissory note due on demand that carries a 6% interest rate. The note was cancelled on March
15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
20,000 |
|
| |
|
|
|
|
|
|
|
|
| On March 1, 2022, the Company, through its
wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $400,000 from Dr. John McCabe, an affiliate investor, pursuant
to an unsecured promissory note, maturing on January 1, 2024, that carries an 8% interest rate. The note was cancelled on March 15,
2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
400,000 |
|
| |
|
|
|
|
|
|
|
|
| On February 15, 2022, the Company, through
its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $200,000 from Dr. John McCabe, an affiliate investor, pursuant
to an unsecured promissory note, maturing on January 1, 2024, that carries an 8% interest rate. The note was cancelled on March 15,
2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
200,000 |
|
| |
|
|
|
|
|
|
|
|
| On December 29, 2021,
the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $200,000 from Dr. Kenneth Perego, II,
M.D., our Vice Chairman of the Board, pursuant to an unsecured promissory note due January 1, 2024 that carries an 8% interest rate.
The note was cancelled on March 15, 2024, in exchange for the note maturing on March 1, 2027, listed above. |
|
|
- |
|
|
|
200,000 |
|
| |
|
|
|
|
|
|
|
|
| Total notes payable, related parties |
|
|
2,450,981 |
|
|
|
1,146,500 |
|
| Less:
unamortized debt discounts |
|
|
9,729 |
|
|
|
- |
|
| Notes payable, related
parties, net of discounts |
|
|
2,441,252 |
|
|
|
1,146,500 |
|
| Less:
current maturities |
|
|
- |
|
|
|
1,146,500 |
|
| Notes payable, related
parties, long-term portion |
|
$ |
2,441,252 |
|
|
$ |
- |
|
|